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Abstract
The homeodomain transcription factor vHNF1 plays an essential role in the patterning of the caudal segmented hindbrain, where it participates
in the definition of the boundary between rhombomeres (r) 4 and 5 and in the specification of the identity of r5 and r6. Understanding the
molecular basis of vHnf1 own expression therefore constitutes an important issue to decipher the regulatory network governing hindbrain
patterning. We have identified a highly conserved 800-bp enhancer element located in the fourth intron of vHnf1 and whose activity recapitulates
vHnf1 neural expression in transgenic mice. Functional analysis of this enhancer revealed that it contains two types of essential motifs, a retinoic
acid response element and two half T-MARE sites, indicating that it integrates direct inputs from the retinoic acid signaling cascade and
MAF-related factors. Our data suggest that MAFB, which is itself regulated by vHNF1, acts as a positive modulator of vHnf1 in r5 and r6,
whereas another MAF-related factor is absolutely required for the expression of vHnf1 in both the hindbrain and the spinal cord. We propose a
model accounting for the initiation and maintenance phases of vHnf1 expression and for the establishment of the r4/r5 boundary, based on
cooperative contributions of Maf factors and retinoic acid signaling.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hindbrain segmentation; Pattern formation; Transcriptional enhancers; MAFBIntroduction
The vertebrate hindbrain is subjected to a transient seg-
mentation process along the anteroposterior (AP) axis that
results in the establishment of a series of 7/8 metameric
transversal territories called rhombomeres (r) (Lumsden and
Keynes, 1989; Lumsden and Krumlauf, 1996). This subdivision
presages the stereotyped pattern of neuronal differentiation in
the hindbrain (Clarke et al., 1998; Lumsden and Keynes, 1989).
It also underlies the pathways of neural crest cell migration into
the branchial arches and participates in their patterning
(Ghislain et al., 2003; Lumsden et al., 1991; Serbedzija et al.,
1992; Trainor and Krumlauf, 2000; Trainor et al., 2002 and
references therein), thus playing an essential role in craniofacial
morphogenesis.⁎ Corresponding author.
E-mail address: charnay@biologie.ens.fr (P. Charnay).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.07.003Numerous genes, including a large proportion of transcrip-
tion factor genes, have been shown to present evolutionarily
conserved, restricted patterns of expression along the AP axis,
with limits corresponding to prospective or established
rhombomere boundaries (reviewed in Lumsden and Krumlauf,
1996), and many of them have been implicated at different
levels of the segmentation process (see Chomette et al., 2006 for
references). Understanding the principles governing hindbrain
segmentation will clearly require to decipher the details of the
regulation of these segmentally restricted genes themselves.
Although data are still limited on this matter, they suggest that
the initial establishment and later evolution of their expression
patterns result from the combination of at least three types of
inputs: morphogenetic gradients of diffusible signaling mole-
cules such as retinoic acid (RA), Fgf and Wnt (Dupe and
Lumsden, 2001; Gavalas and Krumlauf, 2000; Kudoh et al.,
2002; Marin and Charnay, 2000; Nordstrom et al., 2006; Walshe
et al., 2002), cross-regulations between the segmentally
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1997; Sham et al., 1993) and autoregulatory mechanisms
(Chomette et al., 2006; Manzanares et al., 2001; Popperl et al.,
1995).
vHnf1 (variant hepatocyte nuclear factor 1, also known as
Hnf1β or Tcf2) is one of these evolutionarily conserved,
segmentally restricted genes, playing an essential role in
hindbrain development. It encodes a transcription factor with
an atypical homeodomain, closely related to HNF1α (De
Simone et al., 1991; Rey-Campos et al., 1991). In the mouse
neural tube vHnf1 expression is initiated at around embryonic
day (E) 7.8 in the caudal hindbrain and spinal cord, and at E8 its
anterior limit was shown to coincide with prospective r4/r5
boundary (Barbacci et al., 1999; Coffinier et al., 1999; Sirbu et
al., 2005), as in other vertebrate species (Aragon et al., 2005;
Lecaudey et al., 2004; Sun and Hopkins, 2001). Later this
anterior limit progressively retracts posteriorly in the hindbrain
and the spinal cord expression becomes restricted to the roof
plate and a ventral region (Aragon et al., 2005; Barbacci et al.,
1999; Coffinier et al., 1999; Lecaudey et al., 2004). Knock-out
of the mouse gene was shown to be lethal around E6 due to the
absence of extraembryonic visceral endoderm where vHnf1 is
also expressed (Barbacci et al., 1999; Coffinier et al., 1999).
Recent work in the zebrafish has shown that impairment of
vHnf1 function leads to mis-specification of r5 and r6, which
acquire r4-like identity (Hernandez et al., 2004; Sun and
Hopkins, 2001; Wiellette and Sive, 2003). More precisely,
vHNF1 was shown to repress an r4 fate posterior to the r4/r5
boundary, to cooperate with Fgf signals from r4 in activating
MafB expression in r5 and r6 and to cooperate with MAFB in
establishing r5 and r6 identities, including the direct transcrip-
tional activation of Krox20 in r5 (Chomette et al., 2006;
Hernandez et al., 2004).
Substantial evidence has accumulated to implicate the RA
signaling pathway in the activation of vHnf1 expression and
fixation of its anterior boundary. Depletion of RA during early
embryogenesis, using mutations in the major RA synthesizing
enzyme gene, Raldh2 (Hernandez et al., 2004; Sirbu et al.,
2005), or application of a specific RALDH2 molecular
antagonist (Hernandez et al., 2004; Maves and Kimmel,
2005), led to almost complete abolition of vHnf1 expression.
Conversely, vHnf1 was ectopically induced in the anterior
neural tube following elevation of the endogenous RA level
obtained by treatment with RA (Maves and Kimmel, 2005;
Sirbu et al., 2005) or by preventing RA degradation (Hernandez
et al., 2007). In addition, the fixation of the rostral limit of
vHnf1 expression and therefore of the r4/r5 boundary has also
been shown to involve a mechanism of mutual repression
between vHNF1 and the Iro7 transcription factor (Lecaudey et
al., 2004). However it is not known whether vHnf1 constitutes a
direct target of RA signaling and/or Iro7, or whether their
actions are relayed by other segmentally expressed genes.
Indeed perturbation in the expression of Hox paralogous group
1 genes and of their associated factors genes, Pbx and Meis,
have been shown to dramatically affect vHnf1 expression in
zebrafish (Choe and Sagerstrom, 2004; Waskiewicz et al., 2002)
and some of these genes have been shown to be under RAcontrol (Gould et al., 1998; Langston and Gudas, 1992;
Marshall et al., 1994). Understanding the details of vHnf1
regulation therefore requires the identification of its direct
upstream regulators. In the present work, to initiate such an
analysis, we have searched for the cis-acting regulatory ele-
ments responsible for vHnf1 expression in the hindbrain and
spinal cord. We have screened a 193-kb genomic region
surrounding the mouse gene and identified a highly conserved
800-bp transcriptional enhancer element located in the fourth
intron of vHnf1 and whose activity recapitulates vHnf1 neural
expression in transgenic mice. Analysis of this enhancer
revealed that it contains a conserved RA response element
(RARE) essential for its activity, establishing that vHnf1
constitutes a direct target of RA signaling. The enhancer also
contains two half T-MARE motifs and their mutation abolished
enhancer activity. T-MARE and half T-MARE constitute
binding sites for members of the MAF family of proteins that
are basic-leucine zipper (bZIP) transcription factors belonging
to the AP1 superfamily (for a review see Motohashi et al., 1997,
2002). MAF proteins can homo- and heterodimerize with each
other as well as with other members of the AP1 family such as
Jun and Fos (Kataoka et al., 1994; Matsushima-Hibiya et al.,
1998). Our data indicate that MAFB, which is itself regulated
by vHNF1, acts as a positive modulator of vHnf1 in r5 and r6
and suggest the absolute requirement of (an)other MAF-related
factor(s) for the regulation of vHnf1 in both the hindbrain and
the spinal cord.
Materials and methods
DNA constructions and mutagenesis
BAC clone RPCI23-304H7 was obtained from a mouse genomic library at
the Children's Hospital Oakland Research Institute (BACPAC Resources).
Mouse fragments #2 to 5 were cloned by PCR from the BAC clone using
primers indicated in Supplementary Table S1. Chicken fragments #8 to 12 were
cloned by PCR from chicken BAC clone CH261-68C12 (BACPAC resources)
using primers indicated in Supplementary Table S1. Mutagenesis of the RARE
(Studer et al., 1994) in fragment #5 was performed by PCR using primers
indicated in Supplementary Table S1. Mutagenesis of the MAF-binding sites
(Manzanares et al., 2002) in fragment #5 was performed using the Quickchange
Multi Site Directed Mutagenesis Kit (Stratagene) with primers indicated in
Supplementary Table S1. Fragments #2 to 12 were cloned into pBGZ40 (Yee
and Rigby, 1993) upstream of the minimal β-globin promoter/lacZ reporter
gene.
Generation of transgenic mice, genotyping and in ovo electroporation
Purification of fragments #2 to 7, 10 and 11 and microinjection of fertilized
mouse eggs were performed as described previously (Ghislain et al., 2002; Sham
et al., 1993). Transgenic embryos were identified by PCR with primers indicated
in Supplementary Table S1. BAC RPCI23-304H7 DNA was isolated using
alkaline lysis and cesium chloride gradient ultracentrifugation. It was co-injected
as a supercoiled plasmid in fertilized mouse eggs together with a 1.5-kb vHnf1
minimal promoter-lacZ reporter fragment in equimolar amounts as described
(Chomette et al., 2006). Transgenic embryos were identified by PCR using the
BAC vector and minimal promoter-lacZ reporter-specific primers indicated in
Supplementary Table S1. The kreisler allele (Frohman et al., 1993) was
maintained in S129 background and construct #3 transgene in a mixed C57Bl6/
DBA2 background. In ovo electroporation into the chick neural tube was
performed as previously described (Giudicelli et al., 2001) at stages HH8–9 and
embryos were collected at HH11–13 for X-gal staining. Co-electroporation
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BR22E were carried out as previously described (Giudicelli et al., 2003).
Each electroporation experiment included a co-electroporation with a GFP
reporter, pCMV-eGfp (0.2 μg/μl). Only embryos showing efficient eGFP
expression from the midbrain to the spinal cord were retained for the analysis.
Care and use of experimental animals involved in the present work were
performed in accordance with French and European regulations.
RA treatment, whole-mount in situ hybridization and X-gal staining
RA treatment was performed by feeding pregnant transgenic female mice at
7.5 days post coitum (dpc) as previously described (Conlon and Rossant, 1992).
Treated females were fed with retinoic acid diluted in DMSO and mixed with
sunflower seed oil (Sigma). Control females were fed with DMSO alone mixed
with oil. Embryos were collected for X-gal staining half or 1 day after RA
treatment. Single and double whole-mount in situ hybridizations were
performed as previously described (Giudicelli et al., 2001), using mouse
vHnf1 (Ott et al., 1991)- and Krox20 (Wilkinson et al., 1989)-specific probes.
Alkaline phosphatase activity was revealed either in blue/purple or in orange/red
using the NBT/BCIP and INT/BCIP substrates respectively (Roche). X-gal
labeling and co-labeling together with in situ hybridization were performed on
chicken and mouse embryos as previously described (Ghislain et al., 2003),
using Krox20 (Wilkinson et al., 1989) and Hoxb1 (Wilkinson et al., 1989)
probes.
In vitro DNA-binding and in silico analyses
The mouse MAFB protein was expressed in Escherichia coli using the
pET21 vector (Novagen). Extracts from control and MafB-expressing bacteria
were prepared as described previously (Manzanares et al., 2002). Band shift
assays were performed on an SpeI fragment derived from wild-type or mutant
versions of fragment #5 as described (Manzanares et al., 1997). DNAse I
footprinting experiments were performed on a BamHI-EcoRI subclone ofFig. 1. Identification of a vHnf1 neural enhancer. (A) Dorsal view of an E8 mouse em
E8–8.25 transgenic mouse embryos carrying the indicated constructs. (D–G) Dorsa
constructs. All embryos are rostral side up. OS, otic sulcus (approximate level of fufragment #5 as previously described (Manzanares et al., 2002). Labeled
fragments were purified by electrophoresis on a 6% polyacrylamide gel. To
produce mouse RARβ and RXRα, COS-7 cells were transfected with pSG5-
mRarβ or pSG5-mRxrα (kind gifts from C. Rochette-Egly) (Rochette-Egly
et al., 1991) or co-transfected with both using the Fugene 6 Transfection Reagent
(Roche). Nuclear extracts were prepared from control and transfected cells as
previously described (Carpentier et al., 1997), with the following modifications:
complete Protease Inhibitor Cocktail (Roche) was added to buffers A and B and
10 μM ZnCl2 to buffer B. Nuclear extracts were concentrated by ultrafiltration
through Centrikon 30 microconcentrators (Amicon, Millipore) and stored at
−80 °C. Band shift was performed as previously described (Zechel et al., 1994)
using a 65-bp oligonucleotide probe carrying wild-type or mutant versions of the
vHnf1 RARE. For supershift analysis 1 μl of mouse ascite fluid antibody
8β10B2 or 4RX1D12 (kind gifts from C. Rochette-Egly), directed against
mouse RARβ and RXRα respectively, was added to the mix (Rochette-Egly
et al., 1991). Sequence alignments were performed using Dotter (Sonnhammer
and Durbin, 1995), Pipmaker (Schwartz et al., 2000) and ClustalW softwares.
Identification of RARE was obtained using Footer software (Corcoran et al.,
2005).
Results
Delimitation of the genomic region controlling vHnf1
expression in the neural tube
During mouse development, vHnf1 is expressed in the neural
tube with a dynamic pattern whose extension is maximal around
E8 and covers r5, r6 and the spinal cord (Fig. 1A and Sirbu
et al., 2005). To identify the cis-acting regulatory elements that
are responsible for this expression, we analyzed a large genomic
region corresponding to the interval between the two genesbryo in situ hybridized with a vHnf1 probe. (B, C) Dorsal views of X-gal stained
l views of X-gal stained HH13 chick embryos electroporated with the indicated
ture r4/r5 boundary); OV, otic vesicle (level of r5 in the chick).
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clone RPCI23-304H7, that encompasses this genomic domain
(Fig. 2A). To evaluate its transcriptional enhancing activity,
this BAC clone was introduced into the mouse genome by
transgenesis, together with a reporter construct, in which the
lacZ gene is driven by the vHnf1 promoter with 1.5 kb of 5′
flanking sequences (Fig. 2A) and which does not give any
specific expression on its own in transgenic mice (Silvia
Cereghini, personal communication). In half the embryos that
co-integrated the BAC clone and the reporter construct (Fig.
2A, transgene #1, n=4), analysis of β-galactosidase activity by
X-gal staining at E8 revealed expression in r5, r6 and the spinal
cord (Fig. 1B), a pattern very similar to that of the endogenous
vHnf1 gene (Fig. 1A). Of particular interest was the conserva-
tion of the rostral limit of expression at the level of theFig. 2. Functional analysis of vHnf1 cis-acting regulatory sequences. (A, B) Schema
genomic fragments tested by mouse transgenesis and in ovo electroporation experime
relative to the transcription start site of vHnf1 (+1). All fragments except the BAC
human β-globin minimal promoter. The BAC clone was co-injected with a reporter
constructs #5, 6 and 7 the black square represents a retinoic acid response element (m
construct #7). The transcriptional activity of the elements was estimated from the X-g
(−) indicate the presence and absence of β-galactosidase activity in the neural tube of i
embryos analyzed and (r5–r6) and (sc) the number of embryos expressing β-galactosi
transgenic embryos expressing a high level of β-galactosidase in r5–r6, two were als
expression in this territory. nd, Not determined.prospective r4/r5 boundary. These data indicate that cis-acting
regulatory elements essential for vHnf1 neural expression are
likely to be located in a region delimited by the Abc1 and
Ddx52 loci in the mouse genome.
Since the vHnf1 neural expression pattern is conserved
among vertebrates (Aragon et al., 2005; Lecaudey et al., 2004;
Sirbu et al., 2005; Sun and Hopkins, 2001), we hypothesized
that the transcriptional enhancer elements responsible for this
pattern should also be conserved among these species. We
therefore performed a comparison of the genomic region
between the mouse and the chick. Whereas the general
organization is conserved (Figs. 2A, B), the chick domain
(37 kb) is much smaller than the mouse (193 kb). The chick
Abc1/Ddx52 intergenic region was divided into four fragments
(Fig. 2B, #8 to 11), which were cloned into a reporter plasmidtic representations of the mouse (A) and chick (B) vHnf1 loci and of the various
nts. Abc1 and Ddx52 are the next flanking genes. Distances in kilobases (kb) are
clone (construct #1) were cloned upstream the lacZ reporter gene driven by the
construct containing the lacZ gene under the control of the vHnf1 promoter. In
utated in construct #6) and the two black circles MAF-binding sites (mutated in
al staining of transgenic or in ovo electroporated embryos. In the tables, (+) and
n ovo electroporated chick embryos, (n) the total number of E8 transgenic mouse
dase in r5 and r6 and in the spinal cord, respectively. For construct #5, among six
o strongly positive in the spinal cord, whereas the others showed lower levels of
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promoter (Fig. 2B). In the absence of an external transcriptional
enhancer, this reporter plasmid does not lead to significant
β-galactosidase expression in the chick neural tube following in
ovo electroporation (Giudicelli et al., 2003). Fragments #8 and 9
showed no activity in this assay (data not shown), whereas
fragments #10 and 11 led to the activation of the lacZ reporter,
in the entire neural tube for fragment #10 (Fig. 1D), and
caudally to the prospective r4/r5 boundary (level of the anterior
border of the otic vesicle) for fragment #11 (Fig. 1E). These data
suggested that fragments #10 and 11 contained functional
enhancer elements.
Identification of a vHnf1 r5–r6/spinal cord enhancer
To localize possible cis-acting elements present within
fragments #10 and 11, we compared the sequences of both
fragments with the orthologous regions in the mouse genome,
searching for conserved non-coding sequences (CNS). CNS
were identified within each fragment (Fig. 3A). Fragment #10
contains two CNS located in the fourth intron, 200 and 800 bp
long respectively. The two corresponding mouse sequences
were subcloned in a unique fragment, #3, from the BAC. Frag-
ment #10 also contains another, smaller CNS (120 bp) located
in the eighth intron (Fig. 3A), which transcriptional enhancing
activity was not assessed. Fragment #11 contains a unique
CNS 250 bp long (Fig. 3A). The corresponding mouse sequence
was subcloned in fragment #2 from the BAC. β-globin
Promoter-lacZ reporter plasmids carrying fragment #2 or 3
were tested by in ovo electroporation and mouse transgenesis to
determine whether the fragments carry enhancer activities
(Fig. 2A). Surprisingly, although construct #2 recapitulated the
restricted pattern observed with construct #11 by in ovo
electroporation, it did not lead to any lacZ expression in mouse
transgenic embryos (n=10, Fig. 2A and data not shown). To
establish that we had not missed a functional enhancer within
fragment #11 that was not sufficiently conserved, we also tested
fragment #11 in transgenic embryos. Again no activity was
detected (n=8, Fig. 2A). We have already observed this type of
situation in the case of several elements (Chomette et al., 2006;
Ghislain et al., 2003 and data not shown). It might reflect a lack
of stringency in the chick electroporation assay that reveals the
presence of regulatory elements normally active in other tissues
or stages, rather than reveal differences between mouse and
chick regulation since the same behavior is observed with cis-
elements from both species. We have therefore not further
analyzed fragment #2.
In contrast, construct #3 gave consistent results in both
assays: it promoted efficient expression of the reporter in the
hindbrain up to the r4/r5 boundary and in the spinal cord, with a
decreasing gradient toward the node (3 out of 4 transgenic
embryos, Figs. 1C and F, 2A). In addition, the orthologous
chick sequence led to the same activation pattern by in ovo
electroporation (construct #12, Fig. 1G). These data indicate
that we have identified a conserved DNA sequence that
functions as a neural transcriptional enhancer in both chick
and mouse and directs an expression pattern similar to that ofvHnf1. The fact that the larger chick fragment (#10) generated
a less restricted pattern in the chick electroporation assay might
be due to the presence of additional cis-acting sequences in
fragment #10 and to the relaxed character of this assay as
discussed above.
To further analyze the activity of construct #3 and in
particular to determine the time course of reporter gene ex-
pression, we generated three mouse transgenic lines carrying
this construct. Their analysis led to identical results: β-galac-
tosidase activity was first detected around the 0–2 somite stage
(ss) in the neural tube posterior to the otic sulcus, a pattern
identical to that of endogenous gene, although vHnf1 mRNA
accumulation was observed slightly earlier (Fig. 3, compare B,
C to G, H; see also Figs. 6A, E). At 4 ss the anterior limit of
X-gal staining was shown to correspond to the r4/r5 boundary,
similar to the endogenous gene (Fig. 3I and Sirbu et al., 2005),
as indicated by a common rostral limit with the r5 Krox20
domain (Fig. 3D and insert). At the 6 ss the β-galactosidase- and
Krox20-positive domains still largely overlapped in r5, indicat-
ing that the anterior limit of transgene expression lied within this
rhombomere, close to the r4/r5 boundary (Fig. 3E), whereas the
vHnf1 expression domain had already retracted, as shown by the
very limited overlap with Krox20 in r5 (Fig. 3J). At the 8–10 ss
the anterior limit of transgene expression had also clearly
regressed posteriorly within r5 as indicated by double labeling
with the Hoxb1 r4 marker (Fig. 3F), while vHnf1 was not
expressed in r5 anymore and was restricted to the dorsal neural
tube (Fig. 3K). Analysis of transgene expression at later stages
(up to E12.5) revealed a neural tube profile similar to that of the
endogenous gene (Barbacci et al., 1999; Coffinier et al., 1999).
In conclusion, fragment #3 appears to carry an enhancer
activity capable of recapitulating vHnf1 expression in r5/r6 and
the spinal cord between E8 and E12.5. The differences that are
observed with the vHnf1 mRNA profile (slightly delayed
activation around E8 and delayed regression from r5 and from
the ventral neural tube) are likely to be accounted for by the time
required to accumulate β-galactosidase and by the higher
stability of the protein, respectively. Therefore, fragment #3
contains a cis-acting regulatory element likely to be responsible
for vHnf1 neural expression.
A minimal neural enhancer responsible for the initiation of
vHnf1 expression
To precisely define the limits of the r5–r6/spinal cord
enhancer, we tested the activity of two subfragments carrying
the largest of the two conserved regions present in fragment #3
(Fig. 4A). Fragment #4 (800 bp) and fragment #5 (550 bp) were
cloned in the expression construct and assayed by in ovo
electroporation and mouse transgenesis. Fragment #4 led to the
same pattern of reporter expression as fragment #3 in both
assays, except that the level of expression was higher when
tested by electroporation (Figs. 2A and 4B, C, E, F). Con-
struct #5 gave the same profile as construct #4 after chick
electroporation (Fig. 4G), but a difference was noticed in
transgenic embryos: among the six embryos that expressed the
reporter, X-gal labeling was strong in r5–r6 and the spinal cord
Fig. 3. The neural enhancer recapitulates vHnf1 expression during hindbrain segmentation. (A) Homology plots between mouse and chick sequences within chick
fragments #10 and #11 (Fig. 2) generated using the Pipmaker software. The horizontal axis represents the mouse sequence in kilobases (k) and the vertical axis the
percentage of homology between mouse and chick sequences. Mouse sequences between 0 and 44 kb and between 43 and 80 kb are orthologous to chick fragments
#10 and 11, respectively. Only homology superior to 50% is shown. Exons (Ex.) are indicated by black boxes and two fragments containing highly conserved non-
coding sequences (constructs #2 and 3) are delineated by blue lines. (B–F) Dorsal views of embryos from a mouse line transgenic for construct #3 and analyzed for
β-galactosidase activity by X-gal staining. (G–K) Dorsal views of mouse embryos analyzed by in situ hybridization with a vHnf1 probe (purple). Rhombomeres (r)
were identified by in situ hybridization with probes specific for Krox20 (marks r3 and r5 in purple in panels D and E and in orange in panels J and K) and Hoxb1
(F, marks r4 and spinal cord in purple). Inset in panel D corresponds to a flat mount of the indicated area. The somite stages (ss) are indicated. OS, otic sulcus.
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contrast, in the other four embryos, whereas reporter expression
was strong in r5 and r6, it was reduced in the spinal cord (Figs.
2A, 4D and 7D). These data suggest that fragment #4 contains
all the necessary sequences for the activity of fragment #3 and
for normal neural expression of vHnf1. For this reason we did
not investigate the activity of the other block of conservedsequences (200 bp) within fragment #3 (Fig. 4A). Fragment #5
has conserved the r5–r6 enhancer activity but is likely to have
lost some sequences modulating the efficiency of transcriptional
activation in the spinal cord.
Developmental transcription factor genes are often subjected
to direct autoregulation (Chomette et al., 2006). It was therefore
important to determine whether the neural enhancer identified in
Fig. 4. Dissection of the vHnf1 neural enhancer. (A) Homology plots between mouse fragment #3 and the corresponding chick sequences generated using the Pipmaker
software. Two overlapping fragments (#4 and 5) covering the largest highly conserved sequence were analyzed by in ovo electroporation and mouse transgenesis.
(B–G) E8–8.25 transgenic mouse embryos (B–D) and HH13 electroporated chick embryos (E–G) carrying the indicated constructs were analyzed by X-gal staining.
OS, otic sulcus; OV, otic vesicle.
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expression or was simply acting as an autoregulatory element.
To investigate the possibility of a direct autoregulation, we
analyzed element #4 nucleotide sequence for the presence of
vHNF1-binding sites with a known weight matrix (Tronche et
al., 1997). We identified a unique possible vHNF1-binding site
that did not perfectly match the matrix. Furthermore, band shift
experiments performed with an oligonucleotide carrying this
putative site did not lead to any specific retarded band in
presence of cellular extracts containing vHNF1 (data not
shown). These data suggest that fragment #4 does not contain
any functional vHNF1-binding site and is not a direct target of
vHNF1. This conclusion was further supported by in ovo co-
electroporation experiments with construct #4 and a vHnf1
expression plasmid, which showed no modification of reporter
expression in presence of exogenous vHNF1 (data not shown).
In conclusion, altogether our data indicate that we have
delimited a minimal vHnf1 neural enhancer (fragment #4) and a
smaller “core” element (fragment #5) that preserves most of the
activity of the larger enhancer. This enhancer does not behave as
a simple autoregulatory element and is therefore likely to be
responsible for the initiation of vHnf1 expression in r5–r6 and
the spinal cord.
Direct control of vHnf1 expression by RA signaling
As discussed above, several recent studies, involving loss-
and gain-of-function experiments in the mouse (Sirbu et al.,2005) and zebrafish (Hernandez et al., 2004, 2007; Maves and
Kimmel, 2005), have indicated that vHnf1 expression in the
neural tube is controlled by RA signaling. We therefore
investigated the possibility that this regulation is mediated by
the neural enhancer. We first analyzed the consequences of an
increase in the level of RA on the activity of the enhancer. It has
been shown previously that administration of a dose of 20 μg/g
of RA to pregnant females at 7.5 dpc resulted in an anterior shift
of vHnf1 expression in the hindbrain of E8.25 embryos (Sirbu
et al., 2005). We observed a similar modification in reporter
gene expression in the transgenic line carrying construct #3,
with a limited shift at E8 (n=2; Figs. 5B, C) and a significant
one at E8.5 (n=4; Figs. 5D, E). These data indicate that the
vHnf1 neural enhancer is ectopically activated in anterior
territories and therefore responds to RA in a manner similar to
the endogenous gene.
This observation raised the possibility that the neural
enhancer might constitute a direct target for RA signaling. We
therefore performed an in silico search for retinoic acid response
elements (RARE) within the sequence of fragment #4. Only one
putative RARE was identified, belonging to the DR5 type,
composed of two direct repeats separated by five unspecified
base pairs (Fig. 5A). This site is located within the core
enhancer delimited by fragment #5 and is highly conserved
within vertebrate species (Supplementary Fig. 1). This type of
RARE is supposed to bind heterodimers of the nuclear hormone
receptor (RAR) and of its co-receptor (RXR) (Mader et al.,
1993). To demonstrate that this sequence constitutes a bona fide
Fig. 5. Identification of an essential retinoic acid response element within the vHnf1 neural enhancer. (A) Alignment of mouse and chick nucleotide sequences from the
vHnf1 enhancer showing a conserved DR5 RARE (boxed). Dashes indicate conserved residues. The consensus for DR5 RARE is indicated below. The mutations
introduced into the RARE site are indicated above. (B–E) Embryos from a mouse line transgenic for construct #3 treated (C, E) or not (B, D) with retinoic acid (RA) at
E7.5 and analyzed by X-gal staining at E8 (B, C) and E8.5 (D, E). Black brackets indicate the distance between the anterior tip of the embryo and the most anterior
X-gal-positive cells in the neural tube. (F) Bandshift analysis of wild-type (wt) and mutant versions of an oligonucleotide containing the mouse vHnf1 RARE motif
using extracts (ext.) from control (c) and Rarβ and Rxrα expressing (+) COS-7 cells. Specific complexes were identified by supershifting with antibodies (ab) directed
against RARβ or RXRα. Black and grey arrows indicate specific and supershifted complexes, respectively. (G–J) E8–8.25 transgenic mouse embryos (G–H) and
HH13 electroporated chick embryos (I–J) carrying the indicated constructs, which contain either wild-type (G, I) or mutated (H, J) RARE versions of the vHnf1
enhancer, were analyzed by X-gal staining. FP, free probe; OS, otic sulcus; OV, otic vesicle.
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oligonucleotide covering the site and nuclear extracts from
COS-7 cells expressing both RARβ and RXRα proteins. In the
presence of RARβ/RXRα extract a specific retarded band was
observed and supershifted by antibodies directed against RARβ
or RXRα (Fig. 5F). Furthermore, mutation of three nucleotides
within each direct repeat abolished binding (Figs. 5A, F). These
data establish that the vHnf1 neural enhancer contains a RARE
that is able to bind RAR/RXR heterodimers in vitro.
To determine whether this RARE plays a functional role in
vivo, we tested the effect of the same mutations on the activity
of the enhancer (construct #6). The mutated enhancer was
almost completely inactive in both mouse transgenesis and in
ovo electroporation (Figs. 2A, 5G–J). Out of nine transgenic
embryos, only one showed a residual reporter expression in r5and r6 (Fig. 2A and data not shown). These data demonstrate
that the vHnf1 neural enhancer constitutes a direct target of RA
receptors and that RA signaling directly controls initiation of
vHnf1 expression through this enhancer.
MAFB is involved in the modulation of vHnf1 expression in r5
and r6
In search for additional regulators of vHnf1, we investigated
the possible involvement of MAFB. MAFB belongs to the
MAF family of transcription factors, is expressed in r5 and r6
and plays an essential role the development of these rhom-
bomeres (Cordes and Barsh, 1994; Frohman et al., 1993;
Manzanares et al., 1999; Moens et al., 1996).MafB activation in
r5 and r6 occurs later than that of vHnf1 and it has actually been
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2005; Wiellette and Sive, 2003). However, this does not exclude
the possibility of a feedback of MAFB on vHnf1 expression. To
investigate this possibility, we analyzed vHnf1 expression in the
kreisler mutant, in which MafB expression is eliminated in
r5–r6. In this mutant the r5/r6 territories are replaced by a smaller,
so-called rX domain that retains some r6 properties (Frohman
et al., 1993; Manzanares et al., 1999; Moens et al., 1996). In
kreisler embryos vHnf1 expression was normally activated
posterior to the otic sulcus at 0 ss (Figs. 6A and B). However at
5 ss the level of vHnf1 expression was slightly reduced anteriorly,
at the expected level of rX, as compared to wild-type embryos in
r5 and r6, whereas the spinal cord expression was not affectedFig. 6. MAFB is involved in the regulation of vHnf1 expression and of the activ
hybridization at the indicated somite stages (ss) in wild-type (A,C; +/+) or kreisler m
driven by the vHnf1 enhancer (construct #3) was analyzed by X-gal staining at the i
embryos. Panels G′–J′ show higher magnifications of the r5–r6/rX regions from the c
electroporation with construct #5 together with expression vectors for versions of M
(K) or wild type (L). In the presence of ectopic wild-type MAFB, β-galactosidase ex
enhancer (brackets), whereas a mutant MAFB (R22E) that cannot bind to DNA has no
r6 in the kreisler mutant; OV, otic vesicle.(Figs. 6C and D). These data confirm that MAFB is not involved
in the initial activation of vHnf1 and indicate that, in contrast, it
plays a role in a later slight up-regulation in r5 and r6.
Transfer of the construct #3 transgene into a homozygous
kreisler background showed that although reporter gene
expression was normally initiated at around 0 ss, it was
expressed at reduced levels at the level of the rX domain at 6
and 10 ss as compared to controls in r5 and r6 (Figs. 6E–J′).
These data suggest that the neural enhancer mediates the
modulation of vHnf1 by MAFB. Consistently we observed that
in chick co-electroporation experiments the enhancer/reporter
construct is activated by exogenous MAFB rostrally to its
normal domain of activity (Figs. 6K and L).ity of the neural enhancer. (A–D) vHnf1 expression was analyzed by in situ
utant (B, D; kr/kr) mouse embryos. (E–J′) The expression of the lacZ reporter
ndicated somite stages in wild-type (E, G, I) or kreisler mutant (F, H, J) mouse
orresponding pictures. (K, L) Chick embryos analyzed by X-gal staining after co-
AFB carrying a mutation preventing DNA binding (R22E, Kataoka et al., 1994)
pression is detected in a territory anterior to the normal domain of activity of the
effect. OS, otic sulcus; r, rhombomere; rX, transformed territory replacing r5 and
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The implication of MAFB in the modulation of the activity
of the vHnf1 neural enhancer prompted us to investigate
whether this effect involved direct binding of this transcription
factor to the enhancer. Band shift experiments were performed
on fragment #5 using extracts from control and MafB ex-
pressing bacteria. Multiple retarded bands were observed
(indicated by brackets in Fig. 7B), which could be specifically
competed by an oligonucleotide carrying a T-MARE consensus
binding site. Additional band shift experiments performed on
overlapping subfragments allowed the localization of the
binding sites within a 200-bp region at the 5′ end of fragment
#5 (data not shown). This region was subsequently subjected to
DNAse I footprinting analysis on both strands using the same
bacterial extracts. This revealed the existence of two domainsFig. 7. Identification of two functional MAF-binding sites within the vHnf1 neural en
enhancer showing two partially conserved MAF half binding sites (boxed). Dashes
mutations introduced into the MAF sites are indicated above. (B) Bandshift analysis
enhancer using control (c) or MAFB (+) containing E. coli extracts (ext.). The position
addition of increasing amounts of oligonucleotides (comp.) carrying a T-MARE cons
DNAse footprinting analysis of part of the vHnf1 neural enhancer for the presence of
the presence of control (c) or MAFB (+) containing E. coli extracts. The sequences o
(D–E) E8–8.25 mouse embryos transgenic for the indicated constructs, corresponding
enhancer, were analyzed by X-gal staining. FP, free probe; OS, otic sulcus.(designated MAF1 and MAF2) specifically protected by MAFB
(Fig. 7C). Analysis of the corresponding nucleotide sequences
revealed the presence in each of them of a motif with high
similarity to a half so-called T-MARE consensus site (Figs. 7A
and C), which has previously been shown to act as a functional
MAF-binding site (Manzanares et al., 1997, 2002).
To determine whether these MAF-binding sites were playing
a role in enhancer activity, we introduced mutations in both sites
(Fig. 7A) and first analyzed their effect by gel retardation.
Although binding was not completely abolished, it was severely
reduced (Fig. 7B). Aversion of construct #5 carrying the MAF1
and MAF2 mutations (construct #7) was then used to generate
transgenic embryos. Whereas the wild-type enhancer leads to
specific lacZ expression in r5, r6 and spinal cord (Figs. 4D, 5G,
7D), the mutated version was completely inactive in most
transgenic embryos (9 out of 10) (Figs. 2A and 7E) and the onlyhancer. (A) Alignment of mouse and chick nucleotide sequences from the vHnf1
indicate conserved residues. The T-MARE consensus is indicated below. The
of wild-type and mutant (affecting both MAF sites) versions of the vHnf1 neural
s of specific complexes are indicated by brackets. Specificity was established by
ensus binding site (wt) or a mutated version unable to bind the protein (mut). (C)
MAFB protected regions. The fragment was subjected to DNAse I treatment in
f the protected regions are indicated on the right side with the MAF sites boxed.
either to the wild-type (D) or MAF site-mutated (E) versions of the vHnf1 neural
354 M. Pouilhe et al. / Developmental Biology 309 (2007) 344–357positive embryo showed a very low level of expression (data not
shown). This latter activity might be related to the residual MAF
binding of the mutated enhancer. In any case these experiments
demonstrate that the two identified MAF sites play an essential
role in the activity of the vHnf1 neural enhancer, not only in
r5–r6 but also in the spinal cord. This effect cannot be mediated
by MAFB and therefore suggests that other factor(s) binding to
the half T-MARE site, which might also belong to the MAF
family, are required for vHnf1 expression in the hindbrain and
the spinal cord.
Discussion
In this paper we have investigated the regulation of vHnf1,
an essential component of the gene network governing caudal
hindbrain segmentation by identifying a cis-acting element
responsible for its expression in the neural tube. Analysis of this
element revealed that it integrates direct inputs from the RA
signaling cascade and fromMAF-related factors. Our data allow
us to propose a model accounting for the initiation and main-
tenance phases of vHnf1 expression and for the establishment of
the r4/r5 boundary.
A conserved, intronic enhancer controls vHnf1 expression in
the developing neural tube
By combining nucleotide sequence comparisons and func-
tional in vivo assays, we have been able to scan a region of
193 kb around and within the mouse vHnf1 gene and identify an
800-bp sequence located within the fourth intron that is able to
drive transcription of a promoter/reporter construct, closely
recapitulating the pattern of vHnf1 expression in the neural tube
between E8 and E12.5. This enhancer was shown to mediate the
regulation of vHnf1 by RA signaling and is likely to constitute
the essential cis-acting element governing vHnf1 expression in
the neural tube. The comparison of various vertebrate genome
sequences shows that this enhancer is strongly conserved in all
vertebrate species tested (Supplementary Fig. S1 and data not
shown). Indeed it contains a 94-bp Ultra Conserved Region
(UCR) that was previously identified by Sandelin et al. (2004)
(see Supplementary Fig. S1). This strong evolutionary con-
servation of the enhancer sequence is fully consistent with the
equally strong conservation of the vHnf1 expression pattern in
the developing neural tube among vertebrates (Aragon et al.,
2005; Lecaudey et al., 2004; Sirbu et al., 2005; Sun and
Hopkins, 2001), suggesting that this element plays a similar role
in regulating vHnf1 transcription in all vertebrates.
The vHnf1 enhancer integrates direct inputs from RA signaling
and MAF-related factors
Analysis of the vHnf1 neural enhancer revealed that it
contains at least two types of essential motifs, a RARE and two
half T-MARE sites. We have shown that the activity of the
enhancer is modulated by exogenous RA in a manner similar to
the endogenous vHnf1 gene and that the integrity of the RARE
is absolutely required for its activity in the hindbrain and thespinal cord at least between 0 and 8 ss. This suggests that the
RARE is required in particular for the initiation phase of vHnf1
expression. Altogether our data indicate that the neural enhancer
is mediating direct regulation of vHnf1 by RA signaling and that
the RA signal is constantly required for expression until 8 ss at
least.
The analysis of the half T-MARE sites revealed important
additional features of the regulation of vHnf1. Their integrity is
also absolutely necessary for the activity of the enhancer as
measured between 0 and 10 ss, suggesting that they are
constantly required from the initiation of vHnf1 expression.
Furthermore, mutation of these motifs abolishes enhancer
activity in both the hindbrain and the spinal cord. In contrast
inactivation of MAFB does not affect initiation of vHnf1
expression but simply leads to a later, slight down-regulation in
r5 and r6. These data suggest the existence of at least two phases
in the regulation of vHnf1 expression, initiation and main-
tenance, which involve different MAF factors. In both the
hindbrain and spinal cord initiation is strictly dependent on the
binding to the enhancer of both an RAR/RXR heterodimer and
(a) T-MARE-binding factor(s), different from MAFB. In the
maintenance period vHnf1 expression is up-regulated in r5 and
r6 by MAFB. During this phase vHnf1 expression is still strictly
dependent on the binding of the RAR/RXR receptor complex
and of at least another MAF-related factor in the hindbrain and
the spinal cord. These data therefore indicate that the neural
enhancer integrates at least three inputs (RA signaling, MAFB
and another MAF-related factor) to specify the dynamics of
vHnf1 pattern of expression. They also suggest that the RAR/
RXR complex and MAF factors are able to synergistically
cooperate to activate the vHnf1 enhancer. Interestingly RARα
and RARγ have been shown to directly interact with the leucine
zipper region of another factor, p45/NF-E2, in a ligand-
dependent manner and this interaction potentiates RAR
transcriptional activity (Cheng et al., 1997). Since MafB is
itself directly up-regulated by vHNF1 (Kim et al., 2005), our
data provide evidence for the existence of an indirect
autoregulatory loop controlling vHnf1 expression and a possible
explanation for the necessity of MAFB activity for robustMafB
induction by vHNF1 and FGF (Hernandez et al., 2004).
However, this autoregulatory loop requires RA signaling, which
might explain why co-electroporation of the neural enhancer
with a vHnf1 expression vector does not lead to rostral, ectopic
activation of the enhancer or of the endogenous gene (data not
shown and Aragon et al., 2005). Finally, as indicated above, the
neural enhancer contains other highly conserved sequences that
are also likely to bind additional transcription factors involved
in vHnf1 regulation. A detailed mutagenesis will be required to
uncover these putative regulators.
A model for vHnf1 regulation and positioning of the r4/r5
boundary
Our understanding of the characteristics of the neural
enhancer allows us to propose a molecular model for vHnf1
regulation, which itself impacts on the patterning of the caudal
hindbrain. Our proposal further builds on models recently
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expressed in the posterior neural tube with an initial rostral limit
that has been shown to position the r4/r5 boundary (Hernandez
et al., 2004, 2007; Lecaudey et al., 2004). It has been proposed
that it is the level of RA signaling that defines the anterior
extension of vHnf1 expression (Hernandez et al., 2007; Sirbu et
al., 2005). During early developmental stages, RA is synthe-
sized by RALDH2 and the recently identified RA synthesizing
enzyme, CYP1B1 (Chambers et al., 2007; Niederreither et al.,
2000), and at the 0 ss RA levels are supposed to be low rostral to
the r4/r5 boundary due to the expression the CYP26A1 and
CYP26C1 RA degradation enzymes (Hernandez et al., 2007).
Since RXRs and RARs are widely expressed at that stage in the
hindbrain (for a review, see Glover et al., 2006), vHnf1
expression may reflect RA levels. Similarly the progressive
caudal retraction of the vHnf1 expression domain from the
hindbrain is likely to reflect the progressive caudal reduction in
RA levels due to the activation of the third CYP26 enzyme,
CYP26B1 (Hernandez et al., 2007; MacLean et al., 2001).
However at the onset of vHnf1 expression, at around 70%
epiboly in the zebrafish and E7.8 in the mouse, RA signaling is
effective in prospective r4 as shown by the RA-dependent
activation of Hoxa1 and Hoxb1 (Langston and Gudas, 1992;
Marshall et al., 1994) and by the expression pattern of RARE-
lacZ constructs in transgenic mice (Rossant et al., 1991; Sirbu et
al., 2005). To explain the restriction of vHnf1 caudal to the
prospective r4/r5 boundary, at least three types of explanations
can be envisaged. (i) The first one relies on a possible
differential sensitivity of RAREs associated with different
threshold levels of RA signaling in r4 and in more caudal
regions of the neural tube. Hence it was hypothesized that the
difference in the rostral expression limits between Hoxb1 and
vHnf1 was due to the presence of a DR2 RARE in Hoxb1 and
a lower affinity DR1 in the promoter of vHnf1 (Sirbu et al.,
2005). However, this is not likely since the vHnf1 promoter is
not able to drive specific neural tube expression (S. Cereghini,
personal communication) and since the vHnf1 neural enhancer
contains a functional DR5 RARE. (ii) Another possibility is that
the absence of expression of vHnf1 in r4 is due to repression by
another factor. Indeed, loss- and gain-of-function experiments
in the zebrafish have shown that Iro7 (also known as Irx7), a
member of the Iroquois transcription factor family, acts as a
repressor of vHnf1 expression and indeed participates in
positioning its anterior limit of expression (Lecaudey et al.,
2004). However, the mode of action of this factor is not known.
We have used an Iroquois binding weight matrix (Bilioni et al.,
2005) to search for binding sites within the vHnf1 neural
enhancer without success (data not shown), suggesting that Iro7
is not directly acting on the enhancer. The absolute requirement
of the two half T-MARE sites for the activity of the neural
enhancer raises the possibility that Iro7 might act by repression
of the MAF-related factor that binds to these sites. (iii) A third
hypothesis, not exclusive with the previous one, is that the
MAF-related factor is not directly specifying the domain of
activation of vHnf1 but rather its timing. In this case, if
activation by the MAF-related factor occurs at the time that RA
signaling has regressed to the level of the prospective r4/r5boundary, this would establish the rostral limit of vHnf1
expression at this level. Validation of these latter hypotheses
will require the identification of the factors binding to the vHnf1
half T-MARE sites. Despite limited knowledge on Maf family
expression patterns, one member attracted our attention, MafA,
since at the 8 ss stage in the chick embryo, it is expressed along
the entire neural tube with a much lower level in r4 and an up-
regulation in r5 and r6 (see Fig. 2C in Lecoin et al., 2004).
However, our analysis in the mouse embryo did not reveal a
sufficiently early expression to be consistent with an implication
in the initial activation of vHnf1 (data not shown). Therefore,
further work will be required to find the factors binding to the
half T-MARE sites and this may not be a trivial issue, since
MAF factors can heterodimerize with various leucine zipper
proteins.
Acknowledgments
We are grateful to Sylvie Schneider-Maunoury, Silvia
Cereghini and Julien Ghislain for critical reading of the manu-
script. We thank Cécile Rochette-Egly for kindly providing the
plasmids pSG5-mRarβ and pSG5-mRxrα and the related
antibodies 8β10B2 or 4RX1D12 and Silvia Cereghini for
the 1.5 kb vHnf1 promoter/reporter construct and unpublished
communications. This work was supported by grants from
Institut National de la Santé et de la Recherche Médicale,
Ministère de l'Education Nationale, de la Recherche et de la
Technologie (MENRT), Association pour la recherche sur le
Cancer, Association pour la Recherche sur le Sclérose en
Plaque, Association Française contre le Myopatie. M.P. was
supported by predoctoral fellowships from MENRT and
Fondation pour la Recherche Médicale.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2007.07.003.
References
Aragon, F., Vazquez-Echeverria, C., Ulloa, E., Reber, M., Cereghini, S., Alsina,
B., Giraldez, F., Pujades, C., 2005. vHnf1 regulates specification of caudal
rhombomere identity in the chick hindbrain. Dev. Dyn. 234, 567–576.
Barbacci, E., Reber, M., Ott, M.O., Breillat, C., Huetz, F., Cereghini, S., 1999.
Variant hepatocyte nuclear factor 1 is required for visceral endoderm
specification. Development 126, 4795–4805.
Bilioni, A., Craig, G., Hill, C., McNeill, H., 2005. Iroquois transcription factors
recognize a unique motif to mediate transcriptional repression in vivo. Proc.
Natl. Acad. Sci. U. S. A. 102, 14671–14676.
Carpentier, A., Balitrand, N., Rochette-Egly, C., Shroot, B., Degos, L.,
Chomienne, C., 1997. Distinct sensitivity of neuroblastoma cells for
retinoid receptor agonists: evidence for functional receptor heterodimers.
Oncogene 15, 1805–1813.
Chambers, D., Wilson, L., Maden, M., Lumsden, A., 2007. RALDH-
independent generation of retinoic acid during vertebrate embryogenesis
by CYP1B1. Development 134, 1369–1383.
Cheng, X., Reginato, M.J., Andrews, N.C., Lazar, M.A., 1997. The
transcriptional integrator CREB-binding protein mediates positive cross
talk between nuclear hormone receptors and the hematopoietic bZip protein
p45/NF-E2. Mol. Cell. Biol. 17, 1407–1416.
356 M. Pouilhe et al. / Developmental Biology 309 (2007) 344–357Choe, S.K., Sagerstrom, C.G., 2004. Paralog group 1 hox genes regulate
rhombomere 5/6 expression of vhnf1, a repressor of rostral hindbrain fates,
in a meis-dependent manner. Dev. Biol. 271, 350–361.
Chomette, D., Frain, M., Cereghini, S., Charnay, P., Ghislain, J., 2006. Krox20
hindbrain cis-regulatory landscape: interplay between multiple long-range
initiation and autoregulatory elements. Development 133, 1253–1262.
Clarke, J.D., Erskine, L., Lumsden, A., 1998. Differential progenitor dispersal
and the spatial origin of early neurons can explain the predominance of
single-phenotype clones in the chick hindbrain. Dev. Dyn. 212, 14–26.
Coffinier, C., Thepot, D., Babinet, C., Yaniv, M., Barra, J., 1999. Essential role
for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentia-
tion. Development 126, 4785–4794.
Conlon, R.A., Rossant, J., 1992. Exogenous retinoic acid rapidly induces
anterior ectopic expression of murine Hox-2 genes in vivo. Development
116, 357–368.
Corcoran, D.L., Feingold, E., Benos, P.V., 2005. FOOTER: a web tool for
finding mammalian DNA regulatory regions using phylogenetic footprint-
ing. Nucleic Acids Res. 33, W442–W446.
Cordes, S.P., Barsh, G.S., 1994. The mouse segmentation gene kr encodes a
novel basic domain-leucine zipper transcription factor. Cell 79, 1025–1034.
De Simone, V., De Magistris, L., Lazzaro, D., Gerstner, J., Monaci, P.,
Nicosia, A., Cortese, R., 1991. LFB3, a heterodimer-forming homeopro-
tein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 10,
1435–1443.
Dupe, V., Lumsden, A., 2001. Hindbrain patterning involves graded responses
to retinoic acid signalling. Development 128, 2199–2208.
Frohman, M.A., Martin, G.R., Cordes, S.P., Halamek, L.P., Barsh, G.S., 1993.
Altered rhombomere-specific gene expression and hyoid bone differentia-
tion in the mouse segmentation mutant, kreisler (kr). Development 117,
925–936.
Gavalas, A., Krumlauf, R., 2000. Retinoid signalling and hindbrain patterning.
Curr. Opin. Genet. Dev. 10, 380–386.
Ghislain, J., Desmarquet-Trin-Dinh, C., Jaegle, M., Meijer, D., Charnay, P.,
Frain, M., 2002. Characterisation of cis-acting sequences reveals a biphasic,
axon-dependent regulation of Krox20 during Schwann cell development.
Development 129, 155–166.
Ghislain, J., Desmarquet-Trin-Dinh, C., Gilardi-Hebenstreit, P., Charnay, P.,
Frain, M., 2003. Neural crest patterning: autoregulatory and crest-specific
elements co-operate for Krox20 transcriptional control. Development 130,
941–953.
Giudicelli, F., Taillebourg, E., Charnay, P., Gilardi-Hebenstreit, P., 2001.
Krox-20 patterns the hindbrain through both cell-autonomous and non cell-
autonomous mechanisms. Genes Dev. 15, 567–580.
Giudicelli, F., Gilardi-Hebenstreit, P., Mechta-Grigoriou, F., Poquet, C.,
Charnay, P., 2003. Novel activities of Mafb underlie its dual role in
hindbrain segmentation and regional specification. Dev. Biol. 253, 150–162.
Glover, J.C., Renaud, J.S., Rijli, F.M., 2006. Retinoic acid and hindbrain
patterning. J. Neurobiol. 66, 705–725.
Gould, A., Itasaki, N., Krumlauf, R., 1998. Initiation of rhombomeric Hoxb4
expression requires induction by somites and a retinoid pathway. Neuron 21,
39–51.
Hernandez, R.E., Rikhof, H.A., Bachmann, R., Moens, C.B., 2004. vhnf1
integrates global RA patterning and local FGF signals to direct posterior
hindbrain development in zebrafish. Development 131, 4511–4520.
Hernandez, R.E., Putzke, A.P., Myers, J.P., Margaretha, L., Moens, C.B., 2007.
Cyp26 enzymes generate the retinoic acid response pattern necessary for
hindbrain development. Development 134, 177–187.
Kataoka, K., Noda, M., Nishizawa, M., 1994. Maf nuclear oncoprotein
recognizes sequences related to an AP-1 site and forms heterodimers with
both Fos and Jun. Mol. Cell. Biol. 14, 700–712.
Kim, F.A., Singl, A., Kaneko, T., Bieman, M., Stallwood, N., Sadl, V.S., Cordes,
S.P., 2005. The vHNF1 homeodomain protein establishes early rhombomere
identity by direct regulation of kreisler expression. Mech. Dev. 122,
1300–1309.
Kudoh, T., Wilson, S.W., Dawid, I.B., 2002. Distinct roles for Fgf, Wnt and
retinoic acid in posteriorizing the neural ectoderm. Development 129,
4335–4346.
Langston, A.W., Gudas, L.J., 1992. Identification of a retinoic acid responsiveenhancer 3′ of the murine homeobox gene Hox-1.6. Mech. Dev. 38,
217–227.
Lecaudey, V., Anselme, I., Rosa, F., Schneider-Maunoury, S., 2004. The
zebrafish Iroquois gene iro7 positions the r4/r5 boundary and controls
neurogenesis in the rostral hindbrain. Development 131, 3121–3131.
Lecoin, L., Sii-Felice, K., Pouponnot, C., Eychene, A., Felder-Schmittbuhl,
M.P., 2004. Comparison of maf gene expression patterns during chick
embryo development. Gene Expr. Patterns 4, 35–46.
Lumsden, A., Keynes, R., 1989. Segmental patterns of neuronal development in
the chick hindbrain. Nature 337, 424–428.
Lumsden, A., Krumlauf, R., 1996. Patterning the vertebrate neuraxis. Science
274, 1109–1115.
Lumsden, A., Sprawson, N., Graham, A., 1991. Segmental origin and migration
of neural crest cells in the hindbrain region of the chick embryo.
Development 113, 1281–1291.
MacLean, G., Abu-Abed, S., Dolle, P., Tahayato, A., Chambon, P., Petkovich,
M., 2001. Cloning of a novel retinoic-acid metabolizing cytochrome P450,
Cyp26B1, and comparative expression analysis with Cyp26A1 during early
murine development. Mech. Dev. 107, 195–201.
Maconochie, M.K., Nonchev, S., Studer, M., Chan, S.K., Popperl, H., Sham,
M.H., Mann, R.S., Krumlauf, R., 1997. Cross-regulation in the mouse HoxB
complex: the expression of Hoxb2 in rhombomere 4 is regulated by Hoxb1.
Genes Dev. 11, 1885–1895.
Mader, S., Chen, J.Y., Chen, Z., White, J., Chambon, P., Gronemeyer, H., 1993.
The patterns of binding of RAR, RXR and TR homo- and heterodimers to
direct repeats are dictated by the binding specificites of the DNA binding
domains. EMBO J. 12, 5029–5041.
Manzanares, M., Cordes, S., Kwan, C.T., Sham, M.H., Barsh, G.S., Krumlauf,
R., 1997. Segmental regulation of Hoxb-3 by kreisler. Nature 387, 191–195.
Manzanares, M., Trainor, P.A., Nonchev, S., Ariza-McNaughton, L., Brodie, J.,
Gould, A., Marshall, H., Morrison, A., Kwan, C.T., Sham, M.H., Wilkinson,
D.G., Krumlauf, R., 1999. The role of kreisler in segmentation during
hindbrain development. Dev. Biol. 211, 220–237.
Manzanares, M., Bel-Vialar, S., Ariza-McNaughton, L., Ferretti, E., Marshall,
H., Maconochie, M.M., Blasi, F., Krumlauf, R., 2001. Independent
regulation of initiation and maintenance phases of Hoxa3 expression in
the vertebrate hindbrain involve auto- and cross-regulatory mechanisms.
Development 128, 3595–3607.
Manzanares, M., Nardelli, J., Gilardi-Hebenstreit, P., Marshall, H., Giudicelli,
F., Martinez-Pastor, M.T., Krumlauf, R., Charnay, P., 2002. Krox20 and
kreisler co-operate in the transcriptional control of segmental expression of
Hoxb3 in the developing hindbrain. EMBO J. 21, 365–376.
Marin, F., Charnay, P., 2000. Hindbrain patterning: FGFs regulate Krox20
and mafB/kr expression in the otic/preotic region. Development 127,
4925–4935.
Marshall, H., Studer, M., Popperl, H., Aparicio, S., Kuroiwa, A., Brenner, S.,
Krumlauf, R., 1994. A conserved retinoic acid response element required for
early expression of the homeobox gene Hoxb-1. Nature 370, 567–571.
Matsushima-Hibiya, Y., Nishi, S., Sakai, M., 1998. Rat maf-related factors: the
specificities of DNA binding and heterodimer formation. Biochem. Biophys.
Res. Commun. 245, 412–418.
Maves, L., Kimmel, C.B., 2005. Dynamic and sequential patterning of the
zebrafish posterior hindbrain by retinoic acid. Dev. Biol. 285, 593–605.
Moens, C.B., Yan, Y.L., Appel, B., Force, A.G., Kimmel, C.B., 1996. Valentino:
a zebrafish gene required for normal hindbrain segmentation. Development
122, 3981–3990.
Motohashi, H., Shavit, J.A., Igarashi, K., Yamamoto, M., Engel, J.D., 1997. The
world according to Maf. Nucleic Acids Res. 25, 2953–2959.
Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J.D., Yamamoto, M., 2002.
Integration and diversity of the regulatory network composed of Maf and
CNC families of transcription factors. Gene 294, 1–12.
Niederreither, K., Vermot, J., Schuhbaur, B., Chambon, P., Dolle, P., 2000.
Retinoic acid synthesis and hindbrain patterning in the mouse embryo.
Development 127, 75–85.
Nordstrom, U., Maier, E., Jessell, T.M., Edlund, T., 2006. An early role for WNT
signaling in specifying neural patterns of Cdx and Hox gene expression and
motor neuron subtype identity. PLoS Biol. 4, e252.
Ott, M.O., Rey-Campos, J., Cereghini, S., Yaniv, M., 1991. vHNF1 is expressed
357M. Pouilhe et al. / Developmental Biology 309 (2007) 344–357in epithelial cells of distinct embryonic origin during development and
precedes HNF1 expression. Mech. Dev. 36, 47–58.
Popperl, H., Bienz, M., Studer, M., Chan, S.K., Aparicio, S., Brenner, S., Mann,
R.S., Krumlauf, R., 1995. Segmental expression of Hoxb-1 is controlled by a
highly conserved autoregulatory loop dependent upon exd/pbx. Cell 81,
1031–1042.
Rey-Campos, J., Chouard, T., Yaniv, M., Cereghini, S., 1991. vHNF1 is a
homeoprotein that activates transcription and forms heterodimers with
HNF1. EMBO J. 10, 1445–1457.
Rochette-Egly, C., Lutz, Y., Saunders, M., Scheuer, I., Gaub, M.P., Chambon, P.,
1991. Retinoic acid receptor gamma: specific immunodetection and
phosphorylation. J. Cell Biol. 115, 535–545.
Rossant, J., Zirngibl, R., Cado, D., Shago, M., Giguere, V., 1991. Expression of
a retinoic acid response element-hsplacZ transgene defines specific domains
of transcriptional activity during mouse embryogenesis. Genes Dev. 5,
1333–1344.
Sandelin, A., Bailey, P., Bruce, S., Engstrom, P.G., Klos, J.M., Wasserman,
W.W., Ericson, J., Lenhard, B., 2004. Arrays of ultraconserved non-coding
regions span the loci of key developmental genes in vertebrate genomes.
BMC Genomics 5, 99.
Schwartz, S., Zhang, Z., Frazer, K.A., Smit, A., Riemer, C., Bouck, J., Gibbs, R.,
Hardison, R., Miller, W., 2000. PipMaker—A web server for aligning two
genomic DNA sequences. Genome Res. 10, 577–586.
Serbedzija, G.N., Bronner-Fraser, M., Fraser, S.E., 1992. Vital dye analysis of
cranial neural crest cell migration in the mouse embryo. Development 116,
297–307.
Sham, M.H., Vesque, C., Nonchev, S., Marshall, H., Frain, M., Gupta, R.D.,
Whiting, J., Wilkinson, D., Charnay, P., Krumlauf, R., 1993. The zinc finger
gene Krox20 regulates HoxB2 (Hox2.8) during hindbrain segmentation.
Cell 72, 183–196.
Sirbu, I.O., Gresh, L., Barra, J., Duester, G., 2005. Shifting boundaries of
retinoic acid activity control hindbrain segmental gene expression.
Development 132, 2611–2622.
Sonnhammer, E.L., Durbin, R., 1995. A dot-matrix program with dynamicthreshold control suited for genomic DNA and protein sequence analysis.
Gene 167, GC1–GC10.
Studer, M., Popperl, H., Marshall, H., Kuroiwa, A., Krumlauf, R., 1994. Role of
a conserved retinoic acid response element in rhombomere restriction of
Hoxb-1. Science 265, 1728–1732.
Sun, Z., Hopkins, N., 2001. vhnf1, the MODY5 and familial GCKD-associated
gene, regulates regional specification of the zebrafish gut, pronephros, and
hindbrain. Genes Dev. 15, 3217–3229.
Trainor, P.A., Krumlauf, R., 2000. Patterning the cranial neural crest: hindbrain
segmentation and Hox gene plasticity. Nat. Rev., Neurosci. 1, 116–124.
Trainor, P.A., Sobieszczuk, D., Wilkinson, D., Krumlauf, R., 2002. Signalling
between the hindbrain and paraxial tissues dictates neural crest migration
pathways. Development 129, 433–442.
Tronche, F., Ringeisen, F., Blumenfeld, M., Yaniv, M., Pontoglio, M., 1997.
Analysis of the distribution of binding sites for a tissue-specific transcription
factor in the vertebrate genome. J. Mol. Biol. 266, 231–245.
Walshe, J., Maroon, H., McGonnell, I.M., Dickson, C., Mason, I., 2002.
Establishment of hindbrain segmental identity requires signaling by FGF3
and FGF8. Curr. Biol. 12, 1117–1123.
Waskiewicz, A.J., Rikhof, H.A., Moens, C.B., 2002. Eliminating zebrafish pbx
proteins reveals a hindbrain ground state. Dev. Cell 3, 723–733.
Wiellette, E.L., Sive, H., 2003. vhnf1 and Fgf signals synergize to specify
rhombomere identity in the zebrafish hindbrain. Development 130,
3821–3829.
Wilkinson, D.G., Bhatt, S., Chavrier, P., Bravo, R., Charnay, P., 1989. Segment-
specific expression of a zinc-finger gene in the developing nervous system of
the mouse. Nature 337, 461–464.
Yee, S.P., Rigby, P.W., 1993. The regulation of myogenin gene expression
during the embryonic development of the mouse. Genes Dev. 7, 1277–1289.
Zechel, C., Shen, X.Q., Chen, J.Y., Chen, Z.P., Chambon, P., Gronemeyer, H.,
1994. The dimerization interfaces formed between the DNA binding
domains of RXR, RAR and TR determine the binding specificity and
polarity of the full-length receptors to direct repeats. EMBO J. 13,
1425–1433.
